• Home
  • NEW DAY MEDICINE
  • 7 (69) 2024
  • 38 -7 (69) 2024 - Berdiev A.Sh., Akhmedov F.K. - CONTEMPORARY ASPECTS OF BIOCHEMICAL AND IMMUNOLOGICAL MARKERS IN PREGNANT WOMEN WITH RHEUMATIC MITRAL VALVE INSUFFICIENCY

38 -7 (69) 2024 - Berdiev A.Sh., Akhmedov F.K. - CONTEMPORARY ASPECTS OF BIOCHEMICAL AND IMMUNOLOGICAL MARKERS IN PREGNANT WOMEN WITH RHEUMATIC MITRAL VALVE INSUFFICIENCY

CONTEMPORARY ASPECTS OF BIOCHEMICAL AND IMMUNOLOGICAL MARKERS IN PREGNANT WOMEN WITH RHEUMATIC MITRAL VALVE INSUFFICIENCY

Berdiev A.Sh. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Akhmedov F.K. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Among cardiovascular diseases, the incidence of mitral valve regurgitation of rheumatic origin is constantly increasing, and this trend is predicted to continue. Currently, mitral valve insufficiency is rapidly becoming an important problem in the health care system. The number of hospitalizations for this heart disease increases every year, which is a major health problem in low- and middle-income countries. Based on the discovery of new biomarkers to accelerate the early detection of the disease, it is necessary to study and evaluate the diagnostic requirements. Based on the assessment of current trends in the use of cardiovascular markers, we discussed and described the requirements for their use in rheumatic heart disease and other cardiovascular diseases. In addition, this review focuses on cardiovascular biomarkers and procedures that should be considered to create a comprehensive picture of cardiovascular biomarker expression

Keywords: Rheumatic heart disease, cardiovascular disease, rheumatism, mitral valve insufficiency, pregnancy

First page

220

Last page

225

For citation:Berdiev A.Sh., Akhmedov F.K. - CONTEMPORARY ASPECTS OF BIOCHEMICAL AND IMMUNOLOGICAL MARKERS IN PREGNANT WOMEN WITH RHEUMATIC MITRAL VALVE INSUFFICIENCY//New Day in Medicine 7(69)2024 220-225 https://newdayworldmedicine.com/en/new_day_medicine/7-69-2024

List of References

  1. Билич И.Л., Сызганова К.И. Ревматические пороки сердца и беременность //Казанский медицинский журнал. 2021;39(2):85-89.
  2. Клеменов А.В. Дисплазия соединительной ткани и беременность (обзор) / А.В. Клеменов, О.Н. Ткачева, А.Л. Верткин //Тер. архив. 2014;11:80-83.
  3. Насонов E.Л. Биоаналоги в ревматологии. //Научно-практическая ревматология. 2016;54(6):628-640
  4. Шехтман М. М. Руководство по экстрагенитальной патологии у беременных / М. М. Шехтман. 5-е изд. М.: Триада-Х, 2013; 896 с.
  5. Afa B. Features of Rheumatic Disease Management while Pregnancy. Int Gyn & Women’s Health 1(2)-2018. IGWHC.
  6. Avi Sabbag et.al., Mitral valve prolapse: arrhythmic risk during pregnancy and postpartum, //European Heart Journal, 21 May 2024;45(20):1831-1839.
  7. Abe M., Arima H., Yoshida Y., Fukami A., Sakima A., Metoki H., Tada K., Mito A., Morimoto S., Shibata H., et al. Optimal Blood Pressure Target to Prevent Severe Hypertension in Pregnancy: A Systematic Review and Meta-Analysis. //Hypertens. Res. 2022;45:887-899.
  8. Billy McBenedict,,Zaeemah Mansoor.,Abhishek Chaudhary.,Anusha Thomas.,Muhammad Yaseen.,Wilhelmina Hauwanga,Temporal Trends of Age-Adjusted Mortality Rates for Rheumatic Heart Disease in Brazil From 2000 to 2021, Cureus, (2024).
  9. Coad F., Frise C. Tachycardia in Pregnancy: When to Worry? //Clin. Med. 2021;21:e434–e437.
  10. Cui K, Huang W, Fan J, Lei H (2018) Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction. //Medicine 2018;97(36):e12277
  11. D’Alto M., Budts W., Diller G.P., Mulder B., Egidy Assenza G., Oreto L., Ciliberti P., Bassareo P.P., Gatzoulis M.A., Dimopoulos K. Does Gender Affect the Prognosis and Risk of Complications in Patients with Congenital Heart Disease in the Modern Era? //Int. J. Cardiol. 2019;290:156-161.
  12. Dagher M.M., Eichenberger E.M., Addae-Konadu K.L., Dotters-Katz S.K., Kohler C.L., Fowler V.G., Jr., Federspiel J.J. Maternal and Fetal Outcomes Associated with Infective Endocarditis in Pregnancy. //Clin. Infect. Dis. 2021;73:1571-1579.
  13. Garovic V.D., Dechend R., Easterling T., Karumanchi S.A., McMurtry Baird S., Magee L.A., Rana S., Vermunt J.V., August P. Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement from the American Heart Association. //Hypertension. 2022;79: e21–e41.
  14. Kim YS, Karisa N, Jeon WY, Lee H, Kim Y-c, Ahn J (2019) High-level production of N-terminal pro-brain natriuretic peptide, as a calibrant of heart failure diagnosis, Escherichia coli. //Appl Microbiol Biotechnol 2019;103(12):4779-4788.
  15. Kumar M., Saadaoui M., Al Khodor S. Infections and Pregnancy: Effects on Maternal and Child Health. //Front. Cell. Infect. Microbiol. 2022;12:690.
  16. Parsanathan R, Jain SK (2020) Novel invasive and noninvasive cardiac-specific biomarkers in obesity and cardiovascular diseases. //Metab Syndr Relat Disord 2020;18(1):10-30
  17. Patel C., Akhtar H., Gupta S., Harky A. Pregnancy and Cardiac Interventions: What Are the Optimal Management Options? //J. Card. Surg. 2020;35:1589-1596.
  18. Sarhaddi F., Azimi I., Axelin A., Niela-Vilen H., Liljeberg P., Rahmani A.M. Trends in Heart Rate and Heart Rate Variability During Pregnancy and the 3-Month Postpartum Period: Continuous Monitoring in a Free-Living Context. //JMIR mHealth uHealth. 2022;10:e33458.
  19. Tutarel O., Alonso-Gonzalez R., Montanaro C., Schiff R., Uribarri A., Kempny A., Grübler M.R., Uebing A., Swan L., Diller G.-P., et al. Infective Endocarditis in Adults with Congenital Heart Disease Remains a Lethal Disease. //Heart. 2018;104:161-165.
  20. Wang J., Wang A., Cui Y., Wang C., Zhang J. Diagnosis and Treatment of Infective Endocarditis in Pregnancy: A Case Report. //J. Cardiothorac. Surg. 2020;15:109.

    file

    download